According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

A wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...

A team of four mechanical engineering students from South Dakota State University took first place at NASA’s Blue Skies competition with their innovative drone prototypes.

A recent clinical trial published in the Journal of American Medical Association revealed that among individuals who are ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Bariatric surgery for severe obesity including gastric banding is under threat as rocketing indemnity insurance premiums and growing malpractice claims drive surgeons out of the field, experts warn.